CareRx Financials
| CHHHF Stock | USD 1.40 0.00 0.00% |
CareRx |
Understanding current and past CareRx Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CareRx's financial statements are interrelated, with each one affecting the others. For example, an increase in CareRx's assets may result in an increase in income on the income statement.
CareRx Stock Summary
CareRx competes with SNDL, Shuttle Pharmaceuticals, Aurora Cannabis, Teva Pharma, and Elanco Animal. CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada. Carerx Corp operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 1378 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 20 Eglinton Avenue |
| Sector | Food & Staples Retailing |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.carerx.ca |
| Phone | 416 927 8400 |
| Currency | USD - US Dollar |
CareRx Key Financial Ratios
There are many critical financial ratios that CareRx's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CareRx reports annually and quarterly.| Return On Equity | -0.49 | |||
| Return On Asset | 0.0204 | |||
| Beta | 0.79 |
CareRx Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CareRx's current stock value. Our valuation model uses many indicators to compare CareRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CareRx competition to find correlations between indicators driving CareRx's intrinsic value. More Info.CareRx is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CareRx's earnings, one of the primary drivers of an investment's value.CareRx Systematic Risk
CareRx's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CareRx volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was seven with a total number of output elements of fifty-four. The Beta measures systematic risk based on how returns on CareRx correlated with the market. If Beta is less than 0 CareRx generally moves in the opposite direction as compared to the market. If CareRx Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CareRx is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CareRx is generally in the same direction as the market. If Beta > 1 CareRx moves generally in the same direction as, but more than the movement of the benchmark.
CareRx January 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CareRx help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CareRx. We use our internally-developed statistical techniques to arrive at the intrinsic value of CareRx based on widely used predictive technical indicators. In general, we focus on analyzing CareRx Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CareRx's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 15.04 | |||
| Potential Upside | 2.03 |
Complementary Tools for CareRx Pink Sheet analysis
When running CareRx's price analysis, check to measure CareRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareRx is operating at the current time. Most of CareRx's value examination focuses on studying past and present price action to predict the probability of CareRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareRx's price. Additionally, you may evaluate how the addition of CareRx to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |